Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
|
|
Sienna Biopharmaceuticals, Inc. (SNNA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2019 |
4
| Azoy Alexander (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,396 shares
@ $0.23, valued at
$551.1 |
|
| 08/08/2019 |
4
| Andrews Timothy K. (General Counsel & Secretary) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Disposed/sold 60,000 options to buy
@ $15.08, valued at
$904.8k
Disposed/sold 8,518 options to buy
@ $15, valued at
$127.8k
Disposed/sold 18,290 options to buy
@ $2.32, valued at
$42.4k
Disposed/sold 22,500 options to buy
@ $2.32, valued at
$52.2k
Granted 8,518 options to buy
@ $0.71, valued at
$6k
Granted 60,000 options to buy
@ $0.71, valued at
$42.6k
Granted 18,290 options to buy
@ $0.71, valued at
$13k
Granted 22,500 options to buy
@ $0.71, valued at
$16k
|
|
| 08/08/2019 |
4
| Azoy Alexander (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 70,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $20.19, valued at
$504.8k
Disposed/sold 5,600 options to buy
@ $15.08, valued at
$84.4k
Disposed/sold 20,000 options to buy
@ $2.37, valued at
$47.4k
Disposed/sold 8,750 options to buy
@ $2.32, valued at
$20.3k
Granted 25,000 options to buy
@ $0.71, valued at
$17.8k
Granted 5,600 options to buy
@ $0.71, valued at
$4k
Granted 8,750 options to buy
@ $0.71, valued at
$6.2k
Granted 20,000 options to buy
@ $0.71, valued at
$14.2k
|
|
| 08/08/2019 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 55,000 shares
@ $0
Disposed/sold 48,720 options to buy
@ $15.08, valued at
$734.7k
Disposed/sold 11,926 options to buy
@ $15, valued at
$178.9k
Disposed/sold 14,904 options to buy
@ $2.32, valued at
$34.6k
Disposed/sold 22,500 options to buy
@ $2.32, valued at
$52.2k
Granted 11,926 options to buy
@ $0.71, valued at
$8.5k
Granted 48,720 options to buy
@ $0.71, valued at
$34.6k
Granted 14,904 options to buy
@ $0.71, valued at
$10.6k
Granted 22,500 options to buy
@ $0.71, valued at
$16k
|
|
| 08/08/2019 |
4
| Beddingfield III Frederick (President & CEO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 190,910 options to buy
@ $15.08, valued at
$2.9M
Disposed/sold 42,590 options to buy
@ $15, valued at
$638.9k
Disposed/sold 40,968 options to buy
@ $2.32, valued at
$95k
Disposed/sold 93,750 options to buy
@ $2.32, valued at
$217.5k
Granted 42,590 options to buy
@ $0.71, valued at
$30.2k
Granted 190,910 options to buy
@ $0.71, valued at
$135.5k
Granted 40,968 options to buy
@ $0.71, valued at
$29.1k
Granted 93,750 options to buy
@ $0.71, valued at
$66.6k
|
|
| 07/03/2019 |
4
| Stroehmann Diane (See Remarks) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,095 shares
@ $0.76, valued at
$3.1k
|
|
| 07/03/2019 |
4
| Andrews Timothy K. (General Counsel & Secretary) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,095 shares
@ $0.76, valued at
$3.1k
|
|
| 07/03/2019 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,095 shares
@ $0.76, valued at
$3.1k
|
|
| 07/03/2019 |
4
| Azoy Alexander (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,552 shares
@ $0.76, valued at
$1.2k
|
|
| 07/03/2019 |
4
| Beddingfield III Frederick (President & CEO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 17,063 shares
@ $0.76, valued at
$13k
|
|
| 06/03/2019 |
4
| Burow Kristina (10% Owner) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 06/03/2019 |
4
| MORE ROBERT J (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 06/03/2019 |
4
| Leonard Keith R (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 06/03/2019 |
4
| Hindman James M. (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 06/03/2019 |
4
| Harris Todd (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 06/03/2019 |
4
| FENTON DENNIS M (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| MORE ROBERT J (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $2.5, valued at
$250k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Smither John W (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 14,422 options to buy
@ $2.32, valued at
$33.5k
Granted 22,500 options to buy
@ $2.32, valued at
$52.2k
|
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Beddingfield III Frederick (President & CEO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 187,500 shares
@ $0
Granted 40,968 options to buy
@ $2.32, valued at
$95k
Granted 93,750 options to buy
@ $2.32, valued at
$217.5k
|
|
| 08/03/2018 |
4
| Hindman James M. (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $15.15, valued at
$303k
|
|
| 08/03/2018 |
3
| Hindman James M. (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc. |
| 07/17/2018 |
4
| Smither John W (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $16.9, valued at
$338k
|
|
| 06/05/2018 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $15.08, valued at
$150.8k
|
|
| 06/05/2018 |
4
| Burow Kristina (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $15.08, valued at
$150.8k
|
|
|
|
|